“Resistant hypertension is one of the most satisfying diagnoses in vascular medicine — because when we find the underlying renal artery stenosis and treat it, blood pressure that has defeated four medications can normalise with a single angioplasty.”
By Dr. Rahul Agarwal | Consultant Vascular & Endovascular Surgeon, CARE Hospitals, Banjara Hills, Hyderabad
Blood pressure that remains elevated despite three or more antihypertensive medications at optimal doses is called resistant hypertension. It affects approximately 10–15% of hypertensive patients and has a significantly higher cardiovascular risk profile than standard hypertension. In a subset of these patients — those with renal artery stenosis — the cause is not the medications failing but an underlying vascular lesion driving BP through a hormonal mechanism that tablets cannot override.
🨘 What Is Renal Artery Stenosis?
Renal artery stenosis (RAS) is narrowing of one or both arteries supplying the kidneys. The most common cause (90%+) is atherosclerosis — the same plaque-forming process that narrows coronary and leg arteries. A less common cause, particularly in younger women, is fibromuscular dysplasia (FMD) — a non-inflammatory, non-atherosclerotic disease of arterial walls.
🔧 The Mechanism: Why RAS Causes Resistant Hypertension
When a renal artery is significantly narrowed, blood pressure to the kidney drops distal to the stenosis. The kidney interprets this as systemic hypotension and activates the renin-angiotensin-aldosterone system (RAAS):
- Juxtaglomerular cells release renin
- Renin converts angiotensinogen to angiotensin I
- ACE converts angiotensin I to angiotensin II
- Angiotensin II causes intense vasoconstriction and aldosterone release
- Aldosterone causes sodium and water retention
- The result: systemic hypertension that is driven by a hormonal cascade the heart cannot resist regardless of medication dose
ACE inhibitors and ARBs interrupt this cascade and are effective — but in bilateral RAS or single-kidney RAS, they can precipitately reduce GFR and are used cautiously. This is one of the clinical clues: worsening kidney function when started on an ACE inhibitor should raise suspicion for RAS.
🔍 When to Suspect Renal Artery Stenosis
- Hypertension onset before age 30 (especially in women — consider FMD)
- Resistant hypertension: BP uncontrolled despite 3+ medications
- Sudden worsening of previously controlled hypertension
- Flash pulmonary oedema — sudden, recurrent breathlessness in a hypertensive patient without obvious cardiac cause
- Unexplained progressive CKD in a hypertensive patient
- Significant renal asymmetry on imaging (one kidney smaller than the other)
- Abdominal bruit on auscultation (present in 40–60% of RAS cases)
- Acute kidney injury when started on ACE inhibitor or ARB
🧪 Diagnosis
- Duplex renal ultrasound: First-line non-invasive test. Assesses renal artery peak systolic velocity and resistive indices. Sensitivity 85–90% in experienced hands.
- CT angiography or MR angiography: Cross-sectional imaging for anatomical detail, degree of stenosis, and planning intervention
- Digital subtraction angiography (DSA): Gold standard — performed at the time of planned intervention
💉 Treatment
- Atherosclerotic RAS: Medical management (antiplatelet, statin, RAAS blockade, BP control) is first line. Renal artery stenting is reserved for cases with resistant hypertension, recurrent flash pulmonary oedema, or progressive renal impairment despite optimal medical therapy.
- Fibromuscular dysplasia: Percutaneous transluminal angioplasty (without stenting) is highly effective — often achieving cure or dramatic improvement in blood pressure, particularly in younger patients.
❓ Frequently Asked Questions
How do I know if my resistant hypertension is due to renal artery stenosis?
The clinical clues above — particularly sudden onset, worsening despite medication changes, renal size asymmetry, or ACE inhibitor-induced kidney function decline — should prompt investigation with renal duplex ultrasound. Ask your nephrologist or cardiologist specifically whether RAS has been excluded.
Can renal artery stenting cure high blood pressure?
In FMD patients, angioplasty alone often achieves dramatic BP improvement or cure. In atherosclerotic RAS, stenting rarely “cures” hypertension but frequently improves BP control significantly, reduces medication burden, and in selected patients preserves kidney function. Results depend on lesion severity, kidney function, and duration of disease.
🔑 Key Insights: Resistant hypertension (uncontrolled on 3+ medications) may be driven by renal artery stenosis. RAS activates RAAS — a hormonal cascade that medications cannot overcome. Key clues: young onset, worsening without cause, ACE inhibitor-induced renal decline, renal size asymmetry, flash pulmonary oedema. Renal duplex ultrasound is the first investigation. Angioplasty or stenting can dramatically improve BP control in confirmed RAS.
📚 Related Reading
- How High Blood Pressure Destroys Your Arteries
- Hypertension and Peripheral Artery Disease
- Dialysis Access & AV Fistula Surgery
👨⚕️ About the Author
Dr. Rahul Agarwal is a Consultant Vascular & Endovascular Surgeon at CARE Hospitals, Banjara Hills, Hyderabad (MS, DNB). He performs renal artery angioplasty and stenting for renovascular hypertension, and manages the full spectrum of endovascular interventions for complex vascular disease.
Medical Disclaimer: This article is intended for general patient education only and does not constitute individualised medical advice. Always consult a qualified medical professional for diagnosis and treatment specific to your condition.